Trypanothione as a Target in the Design of Antitrypanosomal and Antileishmanial Agents

Authors: Augustyns, K.; Amssoms, K.; Yamani, A.; Rajan, P.K.; Haemers, A.

Source: Current Pharmaceutical Design, Volume 7, Number 12, 1 August 2001 , pp. 1117-1141(25)

Publisher: Bentham Science Publishers

Key:

- Free Content

- New Content

- Subscribed Content

- Free Trial Content

Abstract:

Trypanothione is the key molecule in the defence mechanism of Trypanosoma and Leishmania against oxidative stress. The uniqueness of trypanothione makes the metabolism of this molecule an attractive target in antitrypanosomal and antileishmanial drug design. It became clear that this antioxidant cascade can be considered as the Achilles heel of these parasites.

The following targets and their respective inhibitors will be discussed biosynthesis of trypanothione with glutathionylspermidine synthetase and trypanothione synthetase biosynthesis of glutathione with gama-glutamylcysteine synthetase biosynthesis of spermidine with ornithine decarboxylase trypanothione hydroperoxide metabolism with tryparedoxine peroxidase, tryparedoxine and trypanothione reductase.

Keywords: Trypanothione; Antitrypanosomal; Antileishmanial Agents; oxidative stress; glutathionylspermidine synthetase; trypanothione synthetase; g-glutamylcysteine; spermidine; ornithine; decarboxylase

Document Type: Review article

DOI: 10.2174/1381612013397564

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$55.10 plus tax Refund Policy